Invention Grant
- Patent Title: Chimeric NK receptor and methods for treating cancer
-
Application No.: US14600799Application Date: 2015-01-20
-
Publication No.: US10336804B2Publication Date: 2019-07-02
- Inventor: Tong Zhang , Charles L. Sentman
- Applicant: TRUSTEES OF DARTMOUTH COLLEGE
- Applicant Address: US NH Hanover
- Assignee: TRUSTEES OF DARTMOUTH COLLEGE
- Current Assignee: TRUSTEES OF DARTMOUTH COLLEGE
- Current Assignee Address: US NH Hanover
- Agency: LeClairRyan PLLC
- Agent Robin L. Teskin
- Main IPC: C07K14/705
- IPC: C07K14/705 ; A61K38/10 ; C07K14/715 ; A61K35/17 ; A61K45/06
Abstract:
The present invention relates to chimeric immune receptor molecules for reducing or eliminating tumors. The chimeric receptors are composed a C-type lectin-like natural killer cell receptor, or a protein associated therewith, fused to an immune signaling receptor containing an immunoreceptor tyrosine-based activation motif. Methods for using the chimeric receptors are further provided.
Public/Granted literature
- US20150225470A1 Chimeric NK receptor and methods for treating cancer Public/Granted day:2015-08-13
Information query
